Terms: = Skin cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E
256 results:
1. Fragile hands: targeting nonmelanoma skin cancer on older hands using 595 nm pulsed dye laser.
Herron ED; Snyder AM; Hull CM; LoBello S; Herron MD
Lasers Med Sci; 2024 Apr; 39(1):101. PubMed ID: 38630146
[TBL] [Abstract] [Full Text] [Related]
2. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
[TBL] [Abstract] [Full Text] [Related]
3. Risk factors for medical adhesive-related skin injury at the site of peripherally inserted central venous catheter placement in patients with cancer: a single-centre prospective study from China.
Qi M; Qin Y; Meng S; Feng N; Meng Y
BMJ Open; 2024 Mar; 14(3):e080816. PubMed ID: 38443083
[TBL] [Abstract] [Full Text] [Related]
4. Combined PDE4+MEK inhibition shows antiproliferative effects in NRASQ61 mutated melanoma preclinical models.
Louveau B; Reger De Moura C; Jouenne F; Sadoux A; Allayous C; Da Meda L; Bernard-Cacciarella M; Baroudjian B; Lebbé C; Mourah S; Dumaz N
Melanoma Res; 2024 Apr; 34(2):186-192. PubMed ID: 38141200
[TBL] [Abstract] [Full Text] [Related]
5. Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell Lung cancer Brain Metastases.
Vaios EJ; Shenker RF; Hendrickson PG; Wan Z; Niedzwiecki D; Winter SF; Shih HA; Dietrich J; Wang C; Salama AKS; Clarke JM; Allen K; Sperduto P; Mullikin T; Kirkpatrick JP; Floyd SR; Reitman ZJ
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1507-1518. PubMed ID: 38097090
[TBL] [Abstract] [Full Text] [Related]
6. Melanocytic tumors with spitzoid morphology: correlation of clinicopathologic features and FISH analysis.
Kapişkay DÜ; Ülgen ÖA; İnce Ü; Demirkesen C
Turk J Med Sci; 2023 Aug; 53(4):924-933. PubMed ID: 38031947
[TBL] [Abstract] [Full Text] [Related]
7. Melanocytic Neoplasm With KIT and APC Mutations: A New Subtype of Melanocytoma?
Donati M; Grossmann P; Mansour B; Kazakov DV
Am J Dermatopathol; 2024 Feb; 46(2):107-110. PubMed ID: 37982490
[TBL] [Abstract] [Full Text] [Related]
8. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
9. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract] [Full Text] [Related]
10. Delayed time to radiation and overall survival in Merkel cell carcinoma.
Ma KL; Sharon CE; Tortorello GN; Keele L; Lukens JN; Karakousis GC; Miura JT
J Surg Oncol; 2023 Dec; 128(8):1385-1393. PubMed ID: 37622232
[TBL] [Abstract] [Full Text] [Related]
11. Cause-specific mortality by county, race, and ethnicity in the USA, 2000-19: a systematic analysis of health disparities.
GBD US Health Disparities Collaborators
Lancet; 2023 Sep; 402(10407):1065-1082. PubMed ID: 37544309
[TBL] [Abstract] [Full Text] [Related]
12. Cyclin D1 promotes radioresistance through regulation of RAD51 in melanoma.
Im H; Lee J; Lee HJ; Kim DY; Kim EJ; Yi JY
Exp Dermatol; 2023 Oct; 32(10):1706-1716. PubMed ID: 37421206
[TBL] [Abstract] [Full Text] [Related]
13. Identification of BRAF, ccnd1, and MYC mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
[TBL] [Abstract] [Full Text] [Related]
14. Extracellular Vesicle-Packaged miR-195-5p Sensitizes Melanoma to Targeted Therapy with Kinase Inhibitors.
Santos NL; Bustos SO; Reis PP; Chammas R; Andrade LNS
Cells; 2023 May; 12(9):. PubMed ID: 37174717
[TBL] [Abstract] [Full Text] [Related]
15. Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment in Colombia for Melanoma Patients with Lymph Node Involvement After Complete Resection.
Lopez-Vinueza C; Urrego-Reyes J; Gutierrez FRS; Wurcel V; Zhang S; Jiang S; Jiang R; Zambrano Harvey A; Dhankhar P; Sawhney B; Baluni G; Jain S; Bhadra D
Adv Ther; 2023 Jun; 40(6):2836-2854. PubMed ID: 37129772
[TBL] [Abstract] [Full Text] [Related]
16. Survival in melanoma in the nordic countries into the era of targeted and immunological therapies.
Tichanek F; Försti A; Hemminki A; Hemminki O; Hemminki K
Eur J Cancer; 2023 Jun; 186():133-141. PubMed ID: 37068406
[TBL] [Abstract] [Full Text] [Related]
17. Gain of ccnd1 May Occur Too Infrequently in Cutaneous Melanoma, and Too Late in Melanomagenesis, to Be Diagnostically Useful: Genomic Analysis of 88 Cases.
McFadden JR; Chaudhari AS; Stevanovic M; Tsongalis GJ; Hughes EG; Sriharan A
Am J Dermatopathol; 2023 May; 45(5):311-319. PubMed ID: 36939129
[TBL] [Abstract] [Full Text] [Related]
18. Surgical factors affecting regionally metastatic cutaneous squamous cell carcinoma to the parotid gland.
Rao VM; Feng AL; Deschler DG; Kaufman HL; Lin DT; Miller D; Richmon JD; Shalhout SZ; Varvares MA; Emerick KS
Head Neck; 2023 May; 45(5):1080-1087. PubMed ID: 36891633
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.
Huang R; Shen G; Ren Y; Zheng K; Wang J; Shi Y; Yin JC; Qin L; Zhang G; Zhao M; Su X; Li L; Wang F; Shao Y; Liu B; Zou Z
J Transl Med; 2023 Feb; 21(1):78. PubMed ID: 36739402
[TBL] [Abstract] [Full Text] [Related]
20. Oncogenic signaling pathways and hallmarks of cancer in Korean patients with acral melanoma.
Moon S; Kim HJ; Lee Y; Lee YJ; Jung S; Lee JS; Hahn SH; Kim K; Roh JY; Nam S
Comput Biol Med; 2023 Mar; 154():106602. PubMed ID: 36716688
[TBL] [Abstract] [Full Text] [Related]
[Next]
